Rice Hall James & Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Rice Hall James & Associates’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-246,494	Closed	-$3.04M	–	258
2024 Q4	$3.04M	Sell	246,494 -318,771	-56%	-$3.65M	0.17%	138
2024 Q3	$6.43M	Sell	565,265 -4,824	-0.8%	-$48.4K	0.35%	69
2024 Q2	$4.07M	Buy	570,089 +178,992	+46%	+$1.37M	0.24%	91
2024 Q1	$2.62M	Sell	391,097 -15,761	-4%	-$108K	0.15%	143
2023 Q4	$2.64M	Buy	406,858 +154,770	+61%	+$997K	0.15%	141
2023 Q3	$2.38M	Sell	252,088 -635	-0.3%	-$7.64K	0.15%	146
2023 Q2	$3.53M	Buy	+252,723	New	+$4.31M	0.2%	118

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rice Hall James & Associates's CDMO Position: Q1 2025 in Review

Rice Hall James & Associates sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 246,494 shares — an estimated $3.04M sold.

Rice Hall James & Associates first reported a position in CDMO in Q2 2023 and held it in 7 quarters. The position peaked at $6.43M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Rice Hall James & Associates reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Rice Hall James & Associates sold 246,494 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.04M.
Rice Hall James & Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2023 and held it in 7 quarters.
Rice Hall James & Associates's Avid Bioservices, Inc. Common Stock position peaked at $6.43M in Q3 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Rice Hall James & Associates's 13F filing for Q1 2025, filed 1 May 2025.